摘要
目的比较不同剂量盐酸戊乙奎醚(PHC)预处理对大鼠心肌缺血/再灌注(I/R)损伤的保护作用。方法健康雄性Wistar大鼠48只,按随机数字表法分为空白对照组(Sham)、空白+1.0mg/kgPHC对照组(Sham+H—PHC组)、I/R组、I/R+0.1mg/kgPHC预处理组(I/R+L—PHC组)、I/R+0.3mg/kgPHC预处理组(I/R+M—PHC组)及I/R+1.0mg/kgPHC预处理组(I/R+H—PHC组)6组,每组8只。采用冠状动脉结扎制备心肌I/R损伤模型,于制模前30min给予相应剂量PHC进行预处理。再灌注3h后记录左室舒张期末压(LVEDP)、左室收缩期末压(LVESP)、射血分数(EF)和短轴缩短率(FS);测定血清天冬氨酸转氨酶(AST)、肌酸激酶同工酶(CK—MB)、乳酸脱氢酶(LDH)含量。处死大鼠取心脏,测定心肌缺血面积(AAR)及梗死面积(AI),计算AI/AAR比值;电镜下观察心肌纤维超微结构改变。结果与Sham组和Sham+H—PHC组比较,I/R后各组大鼠均表现为LVEDP增高,LVESP、EF及Fs降低,AST、CK—MB、LDH含量升高,AI/AAR增加。与I/R组比较,不同剂量PHC预处理组LVEDP下降,LVESP、EF、FS升高,AST、CK—MB、LDH含量及AI/AAR比值下降,以中、大剂量PHC组改善最明显[LVEDP(mmHg,1mmHg=0.133kPa):11.33±1.17、9.85±1.09比15.82±1.79,LVESP(mmHg):98.9±10.6、112.8±10.0比87.8±9.2,EF:0.681±0.074、0.741±0.070比0.569±0.072,FS:(42.4±4.6)%、(46.0±5.1)%比(36.8±3.9)%,AST(U/L):386.97±80.65、298.31±54.88比603.47±173.66,CK—MB(U/L):3.12±0.84、2.88±0.72比7.14±1.54,LDH(U/L):1784.23±488.49、1629.37±436.34比2489.14±460.80,AI/AAR比值:0.284±0.014、0.223±0.008比0.377±0.011,均P〈0.05];中、大剂量PHC组比较,仅LVEDP、LYESP和AI/AAR比值差异有统计学意义(均P〈0.05),其余指标比较均P〉0.05。电镜下观察可见:I/R损伤后线粒体明显肿胀,被膜不完整,线粒体嵴消失,结构不完整;中、大剂量PHC预处理组线粒体肿胀减轻,被膜逐渐完整,线粒体嵴可见,结构完整,以大剂量PHC预处理组效果最好,基本接近正常。结论PHC预处理对心肌I/R损伤有明显的保护作用。中剂量PHC(0-3mg/kg)和大剂量PHC(1.0mg/kg)对心肌I/R损伤的保护作用明显优于小剂量PHC(0.1mg/kg),大剂量PHC的保护作用优于中剂量PHC。
Objective To compare the protective effect of different dose of penehyclidine hydrochloride (PHC) in rats with myocardial ischemia/reperfusion (I/R) injury. Methods Forty-eight healthy male Wistar rats were randomly divided into six groups (n = 8 each): sham group, sham + 1.0 mg/kg PHC group (sham + H-PHC group), I/R group, I/R + 0.1 mg/kg PHC preconditioning group (I/R + L-PHC group), I/R + 0.3 mg/kg PHC preconditioning group (I/R + M-PHC group), and I/R + 1.0 mg/kg PHC preconditioning group (I/R + H-PHC group). I/R injury model was reproduced by ligation followed by release of the coronary artery, and PHC in different dosages was given at 30 minutes before model reproduction. At 3 hours after reperfusion, the left ventricular end-diastolic pressure (LVEDP), left ventricular end-systolic pressure (LVESP), ejection fraction (EF), and fractional shortening (FS) were recorded. The levels of aspertate aminotransferase (AST), MB isoenzyme of creatine kinase (CK-MB), and lactate dehydrogenase (LDH) were determined. The myocardial tissues were harvested for the determination of the area at risk (AAR) and the infarct area (AI), and the percentage of AI/AAR was calculated. The examination of myocardial fiber was performed with electron microscopy. Results Compared with sham and sham + H-PHC groups, LVEDPwas increased in I/R groups, LVESP, EF and FS were decreased, and the levels of AST, CK-MB and LDH, as well as the AI/AAR were increased. Compared with I/R group, in pretreatment groups with different doses of PHC, LVEDP was decreased, LVESP, EF and FS were increased, the levels Of AST, CK-MB, LDH, and AI/AAR were also decreased, especially in I/R+M-PHC and I/R+H-PHC groups [LVEDP (mmHg, 1 mmHg = 0.133 kPa): 11.33± 1.17, 9.85 ±1.09 vs. 15.82± 1.79, LVESP ( mmHg ): 98.9 ±10.6, 112.8 ±10.0 vs. 87.8±9.2, EF: 0.681 ± 0.074, 0.741 ± 0.070 vs. 0.569±0.072, FS: (42.4±4.6)%, (46.0±5.1)% vs. (36.8±3.9)%, AST (U/L): 386.97±80.65, 298.31±54.88 vs. 603.47±173.66, CK-MB (U/L): 3.12±0.84, 2.88±0.72 vs. 7.14±1.54, LDH (U/L): 1 784.23±488.49, 1 629.37 ± 436.34 vs. 2 489.14 ± 460.80, AI/AAR: 0.284± 0.014, 0.223 ±0.008 vs. 0.377 ±0.011, all P 〈 0.05 ]. There was significant difference in LVEDP, LVESP, and AI/AAR between I/R + M-PI-IC group and I/R + H-PHC group (all P 〈 0.05 ), and no significant difference in other parameters (all p 〉 0.05 ). It was showed by electron microscopic examination that after I/R injury, the myocyte mitochondria membranes were broken, mitochondria were markedly swollen, mitochondrial cristae disappeared; however in I/R+M-PHC and I/R+H-PHC groups, mitochondrial swelling was mild, the capsule was more or less intact, mitochondrial cristae were partly visible, the structure was complete, especially in the group I/R+H-PHC, and the mitochondrial structure was close to normal. Conclusions PHC could protect myocardial from I/R injury. Mid dose of PHC (0.3 mg/kg) and high dose of PHC ( 1.0 mg/kg) could provide better protective effect than low dose of PHC (0.1 mg/kg), and high dose of PHC is better in effect than the middle dose.
出处
《中华危重病急救医学》
CAS
CSCD
北大核心
2015年第12期955-958,共4页
Chinese Critical Care Medicine
基金
国家自然科学基金(81471902)
北京市卫生系统高层次卫生技术人才培养项目(2013-2-004)
关键词
缺血/再灌注损伤
心肌
盐酸戊乙奎醚
预处理
Ischemia/reperfusion injury, myocardial
Penehyclidine hydrochloride
Preconditioning